| jjjj/mm |
titel |
tijdschrift |
| |
|
|
| 2015 |
The relation of the number of hydrogen bond acceptors with recoveries of immunosuppressants in dried blood spot analysis. |
Bioanalysis |
| 2015 |
Dried blood spot analysis; facing new challenges is. |
Bioanalysis |
| 2015 |
What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis? |
Bioanalysis |
| 2015 |
Dried blood spot analysis of creatinine with LC-MS/MS in addition to immunosuppressants analysis. |
Anal. Bioanal Chem. |
| 2015 |
Analysis of remifentanil with liquid chromatography-tandem mass spectrometry and an extensive stability investigation in EDTA whole blood and acidified EDTA plasma. |
Anesth. Analg. |
| 2015 |
The performance of five different dried blood spot cards for the analysis of six immunosuppressants. |
Bioanalysis |
| 2015 |
Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples |
Bioanalysis |
| 2014 |
Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method. |
Bioanalysis |
| 2014 |
Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse. |
Ther. Drug Monit. |
| 2014 |
Application of sweat patch screening for 16 drugs and metabolites using a fast and highly selective LC-MS/MS method. |
Ther. Drug Monit. |
| 2014 |
Therapeutic drug monitoring by dried blood spot: progress to date and future directions. |
Clin. Pharmacokinet. and future directions. |
| 2014 |
Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS. |
Talanta > |
| 2014/09 |
Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions |
Clin Pharmacokinet |
| 2013 |
Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
|
Talanta /span> |
| 2013 |
Troubleshooting carry-over of LC-MS/MS method for rifampicin, clarithromycin and metabolites in human plasma.
|
J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci. |
| 2013/10 |
Bispectral index values and propofol concentrations at loss and return of consciousness in patients with frontal
brain tumours and control patients
(GCMS propofol analyse in plasma)
|
Britisch Journal of Anaesthesia |
| 2012 |
Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. |
Antimicrob. Agents Chemother. |
| 2011 |
Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. |
J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci. |
| 2009 |
Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. |
Ther. Drug Monit. |
| 2007/10 |
Onderzoekje (analyse UMCG, H. Kuiper) naar anti-luchtziektepillen, die gebruikt zijn tijdens WO-II voor de “D-Day jump” |
Battledetective.com |
| 2007/08 |
Post-mortem cases involving amphetamine-based drugs in the Netherlands: Comparison with driving under the influence cases
|
Forensic Science International |
| 2007/06 |
Gas chromatography–mass spectrometric assay for propofol in cerebrospinal fluid of traumatic brain patients
(GCMS propofol analyse in liquor)
|
Journal of Chromatography
|
| 2005/01 |
Drug use and the severity of a traffic accident
|
Accident Analysis and Prevention |
| 2001/09 |
Driving under the influence of alcohol and/or drugs in the Netherlands 1995–1998 in view of the German and Belgian legislation
|
Forensic Science International |
